Newsroom
Category
June 20, 2018
Media contact: Cliff Despres, (210) 562-6517, despres@uthscsa.edu SAN ANTONIO (June 21, 2018) — About half of U.S. children suffer abuse, poverty, parental incarceration and other trauma. These kids face deep emotional, physical and mental scars. How can schools support and help students dealing with trauma? The new Salud America! “Trauma-Sensitive School Action Pack” is a […]
June 7, 2018
Cancers caused by the human papillomavirus (HPV) are a significant public health problem. The National Cancer Institute (NCI)-Designated Cancer Centers fully endorse the goal of eliminating cancers caused by HPV through gender-neutral HPV vaccination and evidence-based cancer screening.
June 6, 2018
Dementia, a decline in mental ability that is severe enough to interfere with the activities of daily life, is not the result of a single mutation in a single gene, said Sudha Seshadri, M.D., professor and founding director of the Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases at UT Health San Antonio. On the […]
May 31, 2018
For the third time in 10 years, UT Health San Antonio has garnered highly competitive National Institutes of Health (NIH) grants to speed the translation of research discovery into improved patient care. UT Health San Antonio will receive $24 million over the next five years under the Clinical and Translational Science Award (CTSA) Program. The […]
May 17, 2018
The Cancer Prevention & Research Institute of Texas (CPRIT) has awarded $6 million to UT Health San Antonio to support the recruitment of internationally known biochemist Patrick Sung, D.Phil. Dr. Sung’s discoveries have increased understanding of how DNA can repair damage induced by radiation, carcinogens and other causes. Cancer cells are particularly effective at repairing […]
May 8, 2018
SAN ANTONIO (May 8, 2018) ― A multi-institution clinical trial involving researchers from UT Health San Antonio shows significantly lower recurrence of bladder cancer in patients who received the chemotherapy drug gemcitabine. The results of the trial were published May 8, 2018, in the Journal of the American Medical Association. Robert Svatek, M.D., a UT […]
